EFDID: 17275EFD: View Filing

Issuer: HORIZON PHARMA, INC. (0001492426) - D

Accession: 0001492426-10-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001492426
  • Entity Name:
    HORIZON PHARMA, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2010)
  • Address:
    1033 SKOKIE BLVD
    SUITE 355
    NORTHBROOK, IL 60062
  • Persons:
    Related Persons 8
    Timothy P. Walbert
    Executive OfficerDirector
    Robert De Vaere
    Executive Officer
    Louis C. Bock
    Director
    Jeff Himawan
    Director
    Jeffrey W. Bird
    Director
    Hubert Birner
    Director
    Peter Johann
    Director
    Jean-Francois Formela
    Director
EDGAR: Offering Information
  • Accession Date:
    05/24/2010
  • First Sale Date:
    04/01/2010
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $0
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Represents the value of the outstanding stock of Horizon Therapeutics, Inc. and Nitec Pharma AG which were exchanged as consideration for the stock reported herein.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
HORIZON PHARMA, INC./s/ Robert J. De VaereRobert J. De VaereExecutive VP, CFO2010-05-17